| QX-314 |
168887 |
amiloride-sensitive cation channel 5, intestinal |
View
|
| QX-314 |
135381 |
sodium channel, voltage-gated, type VII, alpha |
View
|
| QX-314 |
135191 |
sodium channel, voltage-gated, type I, beta |
View
|
| QX-314 |
137182 |
sodium channel, voltage-gated, type IV, alpha polypeptide |
View
|
| QX-314 |
132900 |
sodium channel, voltage-gated, type XI, alpha |
View
|
| QX-314 |
153849 |
sodium channel, nonvoltage-gated 1 alpha |
View
|
| QX-314 |
153848 |
sodium channel, nonvoltage-gated 1 beta |
View
|
| QX-314 |
150734 |
sodium channel, voltage-gated, type V, alpha polypeptide |
View
|
| QX-314 |
165452 |
sodium channel, voltage-gated, type II, beta |
View
|
| QX-314 |
165421 |
sodium channel, voltage-gated, type IX, alpha |
View
|
| QX-314 |
165479 |
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
View
|
| QX-314 |
165775 |
sodium channel, voltage-gated, type VIII, alpha polypeptide |
View
|
| QX-314 |
127667 |
sodium channel, voltage-gated, type 10, alpha polypeptide |
View
|
| QX-314 |
127751 |
sodium channel, nonvoltage-gated 1 gamma |
View
|
| QX-314 |
133117 |
sodium channel, voltage-gated, type I, alpha |
View
|